REGN
Regeneron Pharmaceuticals Inc
BIOTECHNOLOGY · HEALTHCARE
Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology firm headquartered in Westchester County, New York, renowned for its pioneering work in monoclonal antibodies and therapeutic proteins. The company excels in various therapeutic areas, notably oncology, ophthalmology, and immunolo...
$642.59
-1.10% ($7.17)
Volume
1.18M
52W High
$821.11
52W Low
$476.49
Market Cap
$72.60B
Next Earnings Report
Last Reported
Apr 30, 2026 Beat
Actual: $9.47
vs. Consensus: $9.16
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
Apr 30, 2026
1-Day:
-0.80%
5-Day:
-0.68%
Q1 2026
Apr 29, 2026
1-Day:
+3.02%
5-Day:
+3.33%
Q4 2025
Jan 30, 2026
5-Day:
+4.53%
Q3 2025
Oct 30, 2025
1-Day:
-0.34%
5-Day:
-3.98%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q1'26 | $3.61B | +19.0% | 81.4% | 17.8% | $727.2M |
| Q4'25 | $3.88B | +2.5% | 85.0% | 22.7% | $844.6M |
| Q3'25 | $3.75B | +0.9% | 86.1% | 27.4% | $1.46B |
| Q2'25 | $3.68B | +3.6% | 85.6% | 29.4% | $1.39B |
| Q1'25 | $3.03B | -3.7% | 84.7% | 19.5% | $808.7M |
| Q4'24 | $3.79B | +10.3% | 85.1% | 26.1% | $917.7M |
| Q3'24 | $3.72B | +10.7% | 86.8% | 31.7% | $1.34B |
| Q2'24 | $3.55B | +12.3% | 86.5% | 30.2% | $1.43B |
Company Information
Symbol
REGN
Company
Regeneron Pharmaceuticals Inc
Market Cap
$72.60B
Sector
HEALTHCARE
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare REGN with competitors
Side-by-side earnings comparison